Disclosures for "Evaluation of Plasma pTau217 plus Abeta42/40, and pTau217/Abeta42 Ratio as Confirmatory Tests for Amyloid Pathology in Alzheimer’s Disease (AD)"
-
Dr. Winslow has received personal compensation for serving as an employee of Labcorp/Monogram Biosciences. Dr. Winslow has received personal compensation for serving as an employee of Labcorp/Monogram Biosciences. Dr. Winslow has stock in Labcorp. Dr. Winslow has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Chenna has received personal compensation for serving as an employee of LabCorp-monogram Biosciences. Dr. Chenna has stock in LabCorp.
-
Mintzu Lo has received personal compensation for serving as an employee of Labcorp.
-
Youssouf Badal has nothing to disclose.
-
Brandon Yee has received personal compensation for serving as an employee of Labcorp. Brandon Yee has stock in Lacborp.
-
Mr. Martone has received personal compensation for serving as an employee of Labcorp. Mr. Martone has stock in Pfizer. Mr. Martone has stock in AbbVie. Mr. Martone has stock in Labcorp.
-
Dr. Petropoulos has received personal compensation for serving as an employee of Labcorp-Monogram Biosciences. Dr. Petropoulos has stock in Laboratory Corporation of America Holdings. Dr. Petropoulos has received intellectual property interests from a discovery or technology relating to health care.
-
Christopher Fowler has nothing to disclose.
-
The institution of Prof. Laws has received research support from Multiple Sclerosis Western Australia (MSWA). The institution of Prof. Laws has received research support from Eli Lilly.
-
The institution of Prof. Rainey-Smith has received research support from NHMRC. Prof. Rainey-Smith has received personal compensation in the range of $500-$4,999 for serving as a Grant Assessment Committee Member with NHMRC.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Prof. Masters has nothing to disclose.
-
Dr. Doecke has nothing to disclose.